Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance.

dc.contributor.author	Besada, Emilio
dc.contributor.author	Koldingsnes, Wenche
dc.contributor.author	Nossent, Johannes C
dc.date.accessioned	2013-05-23T07:38:14Z
dc.date.available	2013-05-23T07:38:14Z
dc.date.issued	2013
dc.identifier.citation	EUVAS conference. 13-17.04.2013	en
dc.identifier.cristinID	FRIDAID 1022844
dc.identifier.uri	https://hdl.handle.net/10037/5168
dc.identifier.urn	URN:NBN:no-uit_munin_4882
dc.language.iso	eng	en
dc.rights.accessRights	openAccess
dc.subject	VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759	en
dc.subject	VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759	en
dc.title	Cyclophosphamide effect on immunoglobulins levels in AAV patients treated with long-term pre-emptive rituximab maintenance.	en
dc.type	Conference object	en
dc.type	Konferansebidrag	en